Salesforce Lands $1.6 Billion Veterans Affairs AI Deal, But Institutional Skepticism Lingers

Salesforce shares jump 4.6% on $1.6B VA AI deal, but stock remains down 36% YTD as institutional investors cut stakes and job cuts raise concerns.

A single government contract can shift sentiment in a heartbeat — even when the broader picture remains stubbornly cloudy. Salesforce proved that point on Friday, when shares jumped 4.60 percent to €144.26 after the U.S. Department of Veterans Affairs awarded the software giant a three-year, $1.6 billion agreement to deploy AI agents across its sprawling healthcare network.

The VA, which serves roughly 17 million veterans through 170 medical centers and more than 1,100 clinics, handled 82 million direct care appointments last year alone. Under the "Agentic Enterprise License Agreement," Salesforce will bring its core platform alongside Slack, MuleSoft, and Tableau to accelerate patient triage and case management. The deal is part of a broader push by multiple federal agencies to adopt commercial AI technology — a trend that also lifted rival ServiceNow on the same day.

Yet for all the headline-grabbing size of the contract, the stock remains deep in the red. Salesforce has lost 36.38 percent since the start of the year, and Friday's rally only partially offset a weekly decline of 3.39 percent. The shares still trade roughly 38 percent below their 2025 high from late July.

Strong Earnings, Cautious Guidance

The government win arrives on the heels of a solid quarterly performance. In the first quarter of the current fiscal year, Salesforce earned $3.88 per share — well above the consensus estimate of $3.13. Revenue climbed 13.3 percent year-over-year to $11.13 billion. Management guided for full-year earnings per share between $14.06 and $14.12, with second-quarter EPS expected in the range of $3.25 to $3.27. The company also paid a quarterly dividend of $0.44 per share in early July.

CEO Marc Benioff has pointed to the company's "Agentforce" products as a key growth driver, noting they've already reached an annualized revenue run rate of $1 billion. AI agents have independently handled roughly one million customer conversations. The VA contract represents a large-scale deployment of that technology — not a small pilot, but a full-fledged rollout that could serve as a blueprint for future government and enterprise deals.

Institutional Investors Head for the Exit

Despite the operational progress, big money is moving in the opposite direction. Cumberland Partners slashed its Salesforce stake by 55.8 percent in the first quarter, while Compound Planning cut its position by 22.1 percent. Such rebalancing is not unusual for a widely held stock, but the scale of the reductions stands out against a backdrop of extreme price volatility — the shares have shed 36.63 percent over the past twelve months.

The selloff has a human dimension as well. Reports of 4,000 job cuts, concentrated in customer support, have raised questions about whether untested autonomous systems can reliably replace human staff in critical roles. Broader industry concerns about ballooning AI capital expenditures — at Alphabet, for instance, investment spending has surpassed operating cash flow — could also weigh on Salesforce if the market turns against high-spending tech names.

Technical Hurdles and the Fed Factor

Chart watchers see little reason for celebration yet. Even after Friday's bounce, the stock trades below both its 50-day moving average of €147.84 and its 100-day average of €153.06 — levels that would need to be reclaimed to signal a sustainable recovery. The relative strength index sits at 48.9, neutral territory, while the gap to the 200-day average remains roughly 18 percent negative, confirming a downtrend that has persisted for months.

The next major catalyst is the Federal Reserve's meeting on July 28-29. Markets currently price in a 33 percent probability of a rate hike, a scenario that would pressure richly valued technology stocks. Salesforce's annualized volatility of 42.12 percent underscores just how jittery the tape has become.

Analysts remain broadly constructive, rating the stock a "Moderate Buy" with an average price target of $249.51 — implying roughly 47 percent upside from current levels. But whether the VA contract can rebuild institutional confidence will likely depend on how quickly the new AI agent deals translate into revenue and margin expansion in upcoming quarterly reports.

For now, the €144.26 level is the line in the sand. A break below it opens the door to a retest of the 52-week low of €129.22. A move above the 50-day moving average, by contrast, would offer the first real sign that the stock is stabilizing after its long slide from the July highs.